Anterior-oriented proton beams for prostate cancer: A multi-institutional experience

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30.
   PubMed Web of Science ®Google Scholar
• Mendenhall NP, Hoppe BS, Nichols RC, Mendenhall WM, Morris CG, Li Z, et al. Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2014;88:596–602.
   PubMed Web of Science ®Google Scholar
• Tang S, Both S, Bentefour H, Paly JJ, Tochner Z, Efstathiou J, et al. Improvement of prostate treatment by anterior proton fields. Int J Radiat Oncol Biol Phys 2012;83:408–18.
   PubMed Web of Science ®Google Scholar
• Mah D, Chen C, Cahlon O, Tsai H, Hug E, Hsi W, et al. A method for in vivo intracavitary surface dose validation using thermoluminescent dosimeters (TLDS) applied to prostate cancer patients treated with protons. Int J Radiat Oncol Biol Phys 2013;87:S741–S2.
   Google Scholar
• Slater JD, Rossi CJ, Jr., Yonemoto LT, Bush DA, Jabola BR, Levy RP, et al. Proton therapy for prostate cancer: The initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004;59:348–52.
   PubMed Web of Science ®Google Scholar
• Mayahara H, Murakami M, Kagawa K, Kawaguchi A, Oda Y, Miyawaki D, et al. Acute morbidity of proton therapy for prostate cancer: The Hyogo Ion Beam Medical Center experience. Int J Radiat Oncol Biol Phys 2007; 69:434–43.
   PubMed Web of Science ®Google Scholar
• Nihei K, Ogino T, Onozawa M, Murayama S, Fuji H, Murakami M, et al. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int J Radiat Oncol Biol Phys 2011;81:390–6.
   PubMed Web of Science ®Google Scholar
• Mendenhall NP, Li Z, Hoppe BS, Marcus RB, Jr., Mendenhall WM, Nichols RC, et al. Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:213–21.
   PubMed Web of Science ®Google Scholar
• Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, et al. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer 2014;120:1076–82.
   PubMed Web of Science ®Google Scholar
• Robertson JB, Williams JR, Schmidt RA, Little JB, Flynn DF, Suit HD. Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer 1975;35:1664–77.
   PubMed Web of Science ®Google Scholar
• Britten RA, Nazaryan V, Davis LK, Klein SB, Nichiporov D, Mendonca MS, et al. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam. Radiat Res 2013;179:21–8.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Muren LP, Bentzen L, Hysing LB, Hoyer M, Grau C, et al. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncol 2013;52:521–7.
   PubMed Web of Science ®Google Scholar
• Kung JH, Reft H, Jackson W, Abdalla I. Intensity-modulated radiotherapy for a prostate patient with a metal prosthesis. Med Dosim 2001;26:305–8.
   PubMedGoogle Scholar
• Su A, Reft C, Rash C, Price J, Jani AB. A case study of radiotherapy planning for a bilateral metal hip prosthesis prostate cancer patient. Med Dosim 2005;30:169–75.
   PubMed Web of Science ®Google Scholar
• Brooks C, Cheung RM, Kudchadker RJ. Intensity- modulated radiation therapy with noncoplanar beams for treatment of prostate cancer in patients with bilateral hip prosthesis-a case study. Med Dosim 2010;35:87–91.
   PubMed Web of Science ®Google Scholar
• Fattahi S, Ostapiak OZ. An opposed matched field IMRT technique for prostate cancer patients with bilateral prosthetic hips. J Appl Clin Med Phys 2012;13:3347.
   PubMedGoogle Scholar
• Martin DA, Hruby G, Whitaker MK, Foo KY. Constrained-beam inverse planning for intensity-modulated radiation therapy of prostate cancer patients with bilateral hip prostheses. J Med Imaging Radiat Oncol 2012;56:703–7.
   PubMed Web of Science ®Google Scholar
• van der Est H, Prins P, Heijmen BJ, Dirkx ML. Intensity modulated radiation therapy planning for patients with a metal hip prosthesis based on class solutions. Pract Radiat Oncol 2012;2:35–40.
   PubMedGoogle Scholar
• Kling J, Patel KM. Prostate treatment with helical TomoTherapy in patients with bilateral hip prostheses – two case studies. Med Dosim 2013;38:30–4.
   PubMed Web of Science ®Google Scholar
• Voet PW, Dirkx ML, Breedveld S, Heijmen BJ. Automated generation of IMRT treatment plans for prostate cancer patients with metal hip prostheses: Comparison of different planning strategies. Med Phys 2013;40:071704.
   Google Scholar
• Rana S, Cheng C, Zheng Y, Hsi W, Zeidan O, Schreuder N, et al. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy. J Appl Clin Med Phys 2014;15:4611.
   PubMedGoogle Scholar
• Henderson RH, Hoppe BS, Marcus RB, Jr., Mendenhall WM, Nichols RC, Li Z, et al. Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials. Acta Oncol 2013;52:463–9.
   PubMed Web of Science ®Google Scholar
• Valery R, Mendenhall NP, Nichols RC, Jr., Henderson R, Morris CG, Su Z, et al. Hip fractures and pain following proton therapy for management of prostate cancer. Acta Oncol 2013;52:486–91.
   PubMed Web of Science ®Google Scholar
• Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 J Bone Joint Surg Am 2007;89:780–5.
   PubMed Web of Science ®Google Scholar